Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?
BMJ Evid Based Med
.
2024 Mar 21;29(2):71-74.
doi: 10.1136/bmjebm-2023-112386.
Authors
James Flory
1
,
Jessica S Ancker
2
,
Scott Yung Ho Kim
3
,
Gilad Kuperman
4
,
Andrew Vickers
4
Affiliations
1
Memorial Sloan Kettering Cancer Center, New York, New York, USA floryj@mskcc.org.
2
Vanderbilt University Medical Center, Nashville, Tennessee, USA.
3
Bioethics, National Institutes of Health, Bethesda, Maryland, USA.
4
Memorial Sloan Kettering Cancer Center, New York, New York, USA.
PMID:
37479243
DOI:
10.1136/bmjebm-2023-112386
No abstract available
Keywords:
Information technology.
MeSH terms
Humans
Patient Preference*
Patient Selection